Showing all 7 results
Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). CILNIDIPINE & TELMISARTAN TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed exclusively in secure, high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Telmisartan and light-sensitive Cilnidipine.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg The Hormonal Stabilizer: Blocks the RAAS system to provide 24-hour systemic pressure control and metabolic benefits (PPAR-gamma activation). Cilnidipine USP/Ph.Eur. 10 mg The Vascular Relaxant: Provides immediate N-type and L-type calcium channel blockade to lower peripheral resistance without edema. Excipients Meglumine / Sorbitol / Sodium Hydroxide / Magnesium Stearate / Titanium Dioxide (Opaque Coating) Solubilizer / Diluent / PH Modifier / Light Shield (Engineered specifically utilizing Alkaline Matrix Solubilization. Telmisartan requires a highly alkaline environment to dissolve, while Cilnidipine is light-sensitive. Our bilayer technology ensures each API is released at its peak kinetic window). Clindipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Cardiovascular Tablet, packed exclusively in highly secure, opaque Alu-Alu blister strips to ensure the absolute chemical stability of the highly photosensitive active ingredient.
Active Ingredient Strength Primary Clinical Function Cilnidipine USP/Ph.Eur. 5 mg The Geriatric & Titration Anchor: The definitive starting dose utilized for elderly patients or those with mild essential hypertension to prevent sudden hypotensive episodes. Cilnidipine USP/Ph.Eur. 10 mg The Global Maintenance Standard: The standardized daily therapeutic payload utilized for the vast majority of adult patients requiring chronic 24-hour blood pressure control. Cilnidipine USP/Ph.Eur. 20 mg The Severe Refractory Macrodose: Utilized strictly for severe, uncontrolled hypertension where the 10mg dose has failed to achieve target blood pressure metrics. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Densifier / Superdisintegrant / Binder / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Cilnidipine is intensely sensitive to UV and visible light; this opaque coating guarantees 100% of the active molecule survives to reach the patient’s systemic circulation) *Pack Sizes: 10×10 Opaque Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Perindopril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.
Active Ingredient Strength Primary Clinical Function Perindopril Erbumine Ph.Eur./USP 2 mg Initiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension. Perindopril Erbumine Ph.Eur./USP 4 mg Hypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension. Perindopril Erbumine Ph.Eur./USP 8 mg Cardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium Stearate Diluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
RAMIPRIL & HYDROCLORTHIAZIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
